Equity
€1.1m ▲ 121%
Equity rose in 2025 from €492,955 to €1.1m.
K. BAGHDADI ORL
Lifetime
3 annual accounts with figures on one time axispeak €799,818 (2025)
€799,818▲ 20.6%
peak €595,675 (2025)
€595,675▲ 32.7%
peak €1.1m (2025)
€1.1m▲ 121%
€188,862▲ 16.0%
Board1 name since 2023
1 directorBAGHDADI Khalid
Documentsfilings and deeds
23-06-202638 days before the deadline
2025micro format
Gross margin from €663,014 to €799,818Result from €448,837 to €595,675Registered office moved from Seraing to Boncelles 05-08Equity from €492,955 to €1.1mDebts from €162,858 to €188,862Investments €437,918
Key points
from the 2025 annual accountsTurnover
≈ €1.2m estimated
The micro format states no turnover.
Investments
€440,778 10.9 × depreciation
Green is investment, beige is depreciation. Machinery stands 95.1% higher than in 2024.
Filings
3 annual accounts 1 late
The 2023 accounts came 1 day late. The other two were filed on time.
Starting capital
€1,500 1,000 shares
Position in the sector
€595,675
Higher net result than 95% of companies in human health. Sector median €60,073 · 20,747 companies.
Checked score
97
Excellent
Financially stronger than 79% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,183 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025highest value
07-2025: < 0.1%▼ -0.1 percentage points vs 06-2025lowest value
08-2025: < 0.1%● unchanged vs 07-2025lowest value
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
1 change of registered office in 24 months
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 4.09, cash €335,879
Figures for financial year 2025 (filed on 23-06-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 62% on liquidity, 80% on profitability and 92% on growth.
The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 3,127 companies had the same profile as K. BAGHDADI ORL has now. Each dot stands for 8 companies, two years later.
97.2%
were still trading
1.9%
stopped another way
0.8%
went bankrupt
That fits the bankruptcy probability of K. BAGHDADI ORL itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,127 companies, not a prediction for K. BAGHDADI ORL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €100,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.09 (3.56 in 2024), above the usual 1.5. Short-term debt is 14.7% and cash 26.3% of total assets. 14.8% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-06-2026, 38 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
38 days early
2024
35 days early
2023
1 day late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 3 accounts on average 24 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 June (3 of the last 3 accounts filed within 37 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered office moved from Seraing to Boncelles
New registered office: Rue Fraigneux 46 à 4100 Boncelles · Previous registered office: Rue L. De Brouckère 53 à 4102 SERAING · Board meeting of 26-05-2025 · Gazette deed
Incorporation
Founding capital of €1,500, 1,000 shares · Founder: BAGHDADI Khalid · Appointment: BAGHDADI Khalid (director) · published on 22-06-2023 · Gazette deed
First establishment
Centre ORL du Sart-Tilman, Rue du Sart-Tilman 384, Liège
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| K. BAGHDADI ORL Seraing | €1.3m | €799,818 | 85.2% | - |
| NbCR Brussels | €1.0m | €743,163 | 80.0% | - |
| DR. ANDREAS VANCLOOSTER Tielt | €1.2m | €699,003 | 77.1% | - |
| DOKTER FELIX DELBARE RADIOLOOG Waasmunster | €1.1m | €676,634 | 93.8% | - |
| Dr. Frédéric Vanhove Nazareth-De Pinte | €1.5m | €773,196 | 87.5% | - |
| De Medici TM Antwerp | €1.2m | €684,021 | 93.2% | - |
| CKMS Hasselt | €1.7m | €727,193 | 59.0% | - |
These companies have the same main activity as K. BAGHDADI ORL: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1m and €1.7m, founded between 2022 and 2023.
Official details
Source: KBO- Status
- Active since 20-06-2023Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.346.945.8804031 Liège, since 20-06-2023
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Annual accounts 2025
- €1.3m▲ 85.6%
- Filing
- Filed on 23-06-2026, 38 days before the end of the filing period
Insights on K. BAGHDADI ORL
K. BAGHDADI ORL files the micro format. That format states no turnover. The gross margin rose from €61,064 in 2023 to €799,818 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about K. BAGHDADI ORL
- What is the company number of K. BAGHDADI ORL?
- The company number of K. BAGHDADI ORL is 0802.906.117. The VAT number is the same number with BE in front: BE 0802.906.117.
- Where is K. BAGHDADI ORL based?
- The registered office is at Rue de Fraigneux 46, 4100 Seraing.Company details
- What does K. BAGHDADI ORL do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of K. BAGHDADI ORL?
- K. BAGHDADI ORL is a private limited company (BV).
- When was K. BAGHDADI ORL founded?
- K. BAGHDADI ORL was founded on 20-06-2023.
- Is K. BAGHDADI ORL still active?
- Yes, K. BAGHDADI ORL is an active enterprise in the KBO register.
- What is the turnover of K. BAGHDADI ORL?
- The turnover in financial year 2025 is ≈ €1.2m. This figure is estimated from the gross margin of €799,818 and 30 comparable companies (NACE 86220). It probably lies between €1.1m and €1.7m.Financials
- Is K. BAGHDADI ORL profitable?
- In financial year 2025, K. BAGHDADI ORL made a profit of €595,675.
- Where can I find the annual accounts of K. BAGHDADI ORL?
- K. BAGHDADI ORL filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of K. BAGHDADI ORL due?
- K. BAGHDADI ORL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.